A
Alexion
Organization
Alexion Pharmaceuticals develops therapies for rare diseases, including complement-mediated disorders, and is now part of AstraZeneca.
Organization
Alexion Pharmaceuticals develops therapies for rare diseases, including complement-mediated disorders, and is now part of AstraZeneca.